Women with HPV infection face higher risk of death from cardiovascular disease, finds study

10
Women with HPV infection face higher risk of death from cardiovascular disease, finds study


Women with HPV infection face higher risk of death from cardiovascular disease
Graphical Abstract from EHJ editorial ‘Human papilloma virus and atherosclerotic cardiovascular disease’ Credit: European Heart Journal

Women have a four times higher risk of dying from cardiovascular disease if they have an infection with a high-risk strain of the human papillomavirus (HPV), according to research published in the European Heart Journal today.

HPV is a very common infection and high-risk strains are known to cause . Previous research has suggested that HPV may also contribute to the build-up of dangerous plaque in the arteries. However, this is the first study to show a link between high-risk HPV infection and deaths from .

The research was led by Professors Seungho Ryu, Yoosoo Chang and Hae Suk Cheong from the Sungkyunkwan University School of Medicine, Seoul, Korea. Prof. Ryu said, “Despite remarkable advances in controlling well-known risk factors for heart disease—such as smoking, high cholesterol, hypertension, and diabetes—heart disease continues to be a major cause of death.

“Interestingly, these conventional risk factors don’t explain all heart disease cases; about 20% occur in people who don’t have these issues. This highlights the need to investigate other changeable risk factors. Our research focuses on examining the impact of HPV, particularly in relation to , as a potential risk factor for heart disease.”

The research included 163,250 young or middle-aged Korean women who had no cardiovascular disease at the start of the study. The women were given a variety of health screening tests, including cervical screening for 13 high-risk strains of HPV. The women returned for health checks every year or two for an average of eight and half years.

Researchers were able to combine data on the women’s HPV test results with national data on deaths from cardiovascular disease, including heart disease and stroke.

As a group of relatively young, healthy women, their risk of dying of cardiovascular disease was generally low (9.1 in 100,000 overall).

However, after taking into account other factors that are known to increase the risk of cardiovascular disease, researchers found that women with high-risk HPV had a 3.91 times greater risk of blocked arteries, a 3.74 times greater risk of dying from heart disease and a 5.86 times greater risk of dying from a stroke, compared to women who did not have a high-risk HPV infection. Researchers also found that the risk was higher still in who had a high-risk HPV infection and obesity.

Prof. Cheong said, “We know that inflammation plays a pivotal role in the development and progression of cardiovascular disease and viral infections are potential triggers of inflammation. HPV is known for its link to cervical cancer, but research is starting to show that this virus can also be found in the bloodstream. It can be that the virus is creating inflammation in the blood vessels, contributing to blocked and damaged arteries and increasing the risk of cardiovascular disease.

“This study highlights the importance of comprehensive care for patients with high-risk HPV. Clinicians should monitor cardiovascular health in patients with high-risk HPV, particularly those with obesity or other risk factors. It’s important for people with high-risk HPV to be aware of the potential for both heart disease and cervical cancer risks. They should engage in regular health screenings and adopt a healthy lifestyle to mitigate their risk of cardiovascular disease.”

The researchers say more work is needed to find out whether high-risk HPV infection has similar effects on men and to see if the HPV vaccine can prevent deaths from heart disease. Prof. Ryu added, “If these findings are confirmed, they can have substantial implications for public health strategies. Increasing HPV vaccination rates may be an important strategy in reducing long-term cardiovascular risks.”

In an accompanying editorial Prof. James S. Lawson from the University of New South Wales, Sydney, Australia, and colleagues said, “The evidence that viruses in general and HPV in particular increase the risk of adverse outcomes from atherosclerotic cardiovascular disease has become compelling enough to add to the already strong case for vaccination against influenza virus, SARS-CoV-2, and HPV.

“The evidence that HPV is causal in the initiation or progression of atherosclerotic cardiovascular disease is highly suggestive but might become definitive if the results of randomized trials evaluating HPV vaccines for prevention of cervical cancer showed a reduction in atherosclerotic cardiovascular disease.

“These findings, when added to other evidence linking HPV and other viruses to higher cardiovascular disease mortality, make a strong case for accepting viruses as risk factors for adverse outcomes from atherosclerotic cardiovascular disease.”

More information:
Seungho Ryu et al, Human papillomavirus infection and cardiovascular mortality: a cohort study, European Heart Journal (2024). DOI: 10.1093/eurheartj/ehae020

N.C. Chan, Human papilloma virus and atherosclerotic cardiovascular disease, European Heart Journal (2024). DOI: 10.1093/eurheartj/ehad829

Citation:
Women with HPV infection face higher risk of death from cardiovascular disease, finds study (2024, February 6)
retrieved 6 February 2024
from https://medicalxpress.com/news/2024-02-women-hpv-infection-higher-death.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




Disasters Expo USA, is proud to be supported by Inergency for their next upcoming edition on March 6th & 7th 2024!

The leading event mitigating the world’s most costly disasters is returning to the Miami Beach

Convention Center and we want you to join us at the industry’s central platform for emergency management professionals.
Disasters Expo USA is proud to provide a central platform for the industry to connect and
engage with the industry’s leading professionals to better prepare, protect, prevent, respond
and recover from the disasters of today.
Hosting a dedicated platform for the convergence of disaster risk reduction, the keynote line up for Disasters Expo USA 2024 will provide an insight into successful case studies and
programs to accurately prepare for disasters. Featuring sessions from the likes of The Federal Emergency Management Agency,
NASA, The National Aeronautics and Space Administration, NOAA, The National Oceanic and Atmospheric Administration, TSA and several more this event is certainly providing you with the knowledge
required to prepare, respond and recover to disasters.
With over 50 hours worth of unmissable content, exciting new features such as their Disaster
Resilience Roundtable, Emergency Response Live, an Immersive Hurricane Simulation and
much more over just two days, you are guaranteed to gain an all-encompassing insight into
the industry to tackle the challenges of disasters.
By uniting global disaster risk management experts, well experienced emergency
responders and the leading innovators from the world, the event is the hub of the solutions
that provide attendees with tools that they can use to protect the communities and mitigate
the damage from disasters.
Tickets for the event are $119, but we have been given the promo code: HUGI100 that will
enable you to attend the event for FREE!

So don’t miss out and register today: https://shorturl.at/aikrW

And in case you missed it, here is our ultimate road trip playlist is the perfect mix of podcasts, and hidden gems that will keep you energized for the entire journey

-

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More